Latest & greatest articles for tetracycline

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on tetracycline or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on tetracycline and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for tetracycline

1. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial (Abstract)

Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial Proton pump inhibitor (PPI)-amoxicillin-fluoroquinolone triple therapy is recommended as a second-line treatment of Helicobacter pylori infection in the Maastricht V/Florence Consensus Report. However, the eradication rate of this standard (...) salvage treatment is suboptimal. The objective of this study is to compare the efficacy of esomeprazole-bismuth-tetracycline-levofloxacin therapy (TL quadruple therapy) and esomeprazole-amoxicillin-levofloxacin triple therapy (AL triple therapy) in rescue treatment for H. pylori infection.Consecutive H. pylori-infected subjects after failure of first-line therapies were randomly allocated to receive either TL quadruple therapy (esomeprazole 40 mg b.d., bismuth 120 mg q.d.s., tetracycline 500 mg q.d.s

2017 EvidenceUpdates

2. Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy (Abstract)

Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy To compare the efficacy and safety of bismuth-containing quadruple therapy with tetracycline or amoxicillin for rescue treatment of Helicobacter pylori.The study was a non-inferiority trial of H. pylori eradication with at least two previous treatment failures. Subjects were randomized to receive 14-day therapy with b.i.d. lansoprazole 30 mg (...) and bismuth 220 mg, plus metronidazole 400 mg q.i.d and amoxicillin 1 g t.i.d (amoxicillin group) or tetracycline 500 mg q.i.d (tetracycline group). Antimicrobial susceptibility was assessed by the agar-dilution method. Primary outcome was H. pylori eradication at 6 weeks after treatment.In all, 312 subjects were randomized, 13 were lost to follow-up; 29 violated the protocol. The intention-to-treat, per-protocol, and modified intention-to-treat eradication rates were (amoxicillin) 88.5% (138/156, 95

2016 EvidenceUpdates

3. Novel bioactive tetracycline-containing electrospun polymer fibers as a potential antibacterial dental implant coating Full Text available with Trip Pro

Novel bioactive tetracycline-containing electrospun polymer fibers as a potential antibacterial dental implant coating The purpose of this investigation was to determine the ability of tetracycline-containing fibers to inhibit biofilm formation of peri-implantitis-associated pathogens [i.e., Porphyromonas gingivalis (Pg), Fusobacterium nucleatum (Fn), Prevotella intermedia (Pi), and Aggregatibacter actinomycetemcomitans (Aa)]. Tetracycline hydrochloride (TCH) was added to a poly(DL-lactide (...) . Complete inhibition of biofilm formation on the fibers was observed in groups containing TCH at 10 and 25 wt%. Fibers containing TCH at 5 wt% demonstrated complete inhibition of Aa biofilm. Even though a marked reduction in CFU/mL was observed with an increase in TCH concentration, Pi proved to be the most resilient microorganism. SEM images revealed the absence of or a notable decrease in bacterial biofilm on the TCH-containing nanofibers. Collectively, our data suggest that tetracycline-containing

2016 Odontology

4. Use of Topical Tetracycline-Class Antibiotics Can Reduce Pain and Formation of New Ulcers and Increase Speed of Recovery in Patients with Recurrent Aphthous Stomatitis

Use of Topical Tetracycline-Class Antibiotics Can Reduce Pain and Formation of New Ulcers and Increase Speed of Recovery in Patients with Recurrent Aphthous Stomatitis UTCAT2830, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Use of Topical Tetracycline-Class Antibiotics Can Reduce Pain and Formation of New Ulcers and Increase Speed of Recovery in Patients with Recurrent Aphthous Stomatitis Clinical Question (...) In an adult patient with recurrent aphthous stomatitis, does use of tetracycline-class drugs significantly reduce pain and increase speed of recovery when compared to placebo? Clinical Bottom Line For patients with recurrent aphthous stomatitis, treatment with tetracycline is more effective than placebo in reducing pain and increasing speed of recovery. This is supported by three randomized controlled trials in which various doxycycline formulations showed significantly better healing, pain reduction

2015 UTHSCSA Dental School CAT Library

5. Bismuth + metronidazole + tetracycline (Pylera) for peptic ulcer associated with Helicobacter pylori: why risk adding bismuth?

Bismuth + metronidazole + tetracycline (Pylera) for peptic ulcer associated with Helicobacter pylori: why risk adding bismuth? Prescrire IN ENGLISH - Spotlight ''Bismuth + metronidazole + tetracycline (Pylera°) for peptic ulcer associated with Helicobacter pylori: why risk adding bismuth?'', 1 April 2013 {1} {1} {1} | | > > > Bismuth + metronidazole + tetracycline (Pylera°) for peptic ulcer associated with Helicobacter pylori: why risk adding bismuth? Spotlight Every month, the subjects (...) in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Bismuth + metronidazole + tetracycline (Pylera°) for peptic ulcer associated with Helicobacter pylori: why risk adding bismuth? FEATURED REVIEW The standard treatment for peptic ulcer associated with Helicobacter pylori is a combination of omeprazole, amoxicillin and clarithromycin. The 4-drug regimen comprising omeprazole + bismuth subcitrate

2014 Prescrire

6. Tetracycline

Tetracycline USE OF TETRACYCLINE IN PREGNANCY 0344 892 0909 USE OF TETRACYCLINE IN PREGNANCY (Date of issue: June 2017 , Version: 1.2 ) This is a UKTIS monograph for use by health care professionals. For case-specific advice please contact UKTIS on 0344 892 0909. To report an exposure please download and complete a . Please encourage all women to complete an . A corresponding patient information leaflet on is available at . Summary The tetracyclines are a class of broad-spectrum antibiotics (...) , which despite widespread bacterial resistance, are still useful in the treatment of chlamydia, rickettsia, brucella, Lyme disease, acne, destructive periodontal disease, exacerbations of chronic bronchitis, leptospirosis, and respiratory or genital mycoplasma infections. Available tetracyclines include: tetracycline, demeclocycline, doxycycline, lymecycline, minocycline, oxytetracycline and tigecycline. Doxycycline is also used for malaria prophylaxis in chloroquine-resistant areas

2014 UK Teratology Information Service

7. 6.5% Hydrogen Peroxide and 10% Carbamide Peroxide Effectively Treat Tetracycline-Stained Teeth

6.5% Hydrogen Peroxide and 10% Carbamide Peroxide Effectively Treat Tetracycline-Stained Teeth UTCAT2237, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title 6.5% Hydrogen Peroxide and 10% Carbamide Peroxide Effectively Treat Tetracycline-Stained Teeth Clinical Question In a patient with tetracylcine staining, does the at-home bleaching system successfully whiten teeth as compared to no treatment at all? Clinical Bottom (...) Line 6.5% hydrogen peroxide and 10% carbamide peroxide effectively treat tetracycline-stained teeth. This is supported by a clinical trial that successfully showed patients improved their tooth shade over a 6 month period of time of using a take-home tray-less kit of 6.5% hydrogen peroxide gel. Carbamide peroxide is also an effective treatment that has shown to have lasting effects for at least 90 months after a 6 month treatment course. These treatments are effective options that many patients

2012 UTHSCSA Dental School CAT Library

8. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. (Abstract)

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Helicobacter pylori is associated with benign and malignant diseases of the upper gastrointestinal tract, and increasing antibiotic resistance has made alternative treatments necessary. Our aim was to assess the efficacy and safety of a new, single (...) -capsule treatment versus the gold standard for H pylori eradication.We did a randomised, open-label, non-inferiority, phase 3 trial in 39 sites in Europe, comparing the efficacy and safety of 10 days of quadruple therapy with omeprazole plus a single three-in-one capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline (quadruple therapy) versus 7 days of omeprazole, amoxicillin, and clarithromycin (standard therapy) in adults with recorded H pylori infection. Patients were

2011 Lancet Controlled trial quality: predicted high

9. Should tetracycline treatment be used more extensively for rheumatoid arthritis: metaanalysis demonstrates clinical benefit with reduction in disease activity

Should tetracycline treatment be used more extensively for rheumatoid arthritis: metaanalysis demonstrates clinical benefit with reduction in disease activity Should tetracycline treatment be used more extensively for rheumatoid arthritis: metaanalysis demonstrates clinical benefit with reduction in disease activity Should tetracycline treatment be used more extensively for rheumatoid arthritis: metaanalysis demonstrates clinical benefit with reduction in disease activity Stone M, Fortin P R (...) , Pacheco-Tena C, Inman R D CRD summary This review compared the effect of tetracyclines versus placebo or conventional therapy for rheumatoid arthritis. The authors concluded that tetracyclines given for more than 3 months lead to a reduction in disease activity and acute phase reactants. The review was well-conducted, although apparent clinical differences were not considered in the analysis. Hence, the conclusion should be viewed with caution. Authors' objectives To compare the effectivness

2003 DARE.

10. Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative study. (Abstract)

Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative study. This prospective, multicenter, randomized, "unblinded," controlled clinical trial was designed to determine if the intrapleural instillation of 1500 mg of tetracycline hydrochloride would be effective in diminishing the ipsilateral rate of recurrence for spontaneous pneumothorax. During the 4-year enrollment period, 113 patients were assigned (...) to the tetracycline group; 116 patients were assigned to the control group. During the 5-year study period, the recurrence rate in the tetracycline group (25%) was significantly less than that in the control group (41%). Use of tetracycline seemed to reduce the recurrence rates for patients with either primary or secondary spontaneous pneumothorax and for patients with either an initial or a recurrent pneumothorax. We conclude that the intrapleural administration of tetracycline in patients with spontaneous

1990 JAMA Controlled trial quality: uncertain

11. Spectinomycin versus tetracycline for the treatment of gonorrhea. (Abstract)

Spectinomycin versus tetracycline for the treatment of gonorrhea. Spectinomycin and tetracycline are alternative drugs to penicillin in the treatment of gonorrhea. To compare the efficacy of these agents and their propensity to select resistant gonococci, we treated 4043 patients randomly with either 2 or 4 g of spectinomycin once or 9 g of oral tetracycline for four days. Minimum cure rate for anogenital gonorrhea was 94 per cent with either drug. Oropharyngeal infection responded poorly (...) to spectinomycin in men, with failure of therapy in six of 11. Postgonococcal urethritis in men was less common after tetracycline than after spectinomycin (P less than 0.005). Spectinomycin failure was not related to drug resistance. Tetracycline failure correlated with resistance (P less than 0.0002); one fifth of the isolates resistant to 1.0 mug per milliter of tetracycline were not eradicated. For several reasons, including the appearance of beta-lactamase-producing gonococci, it is no longer clear

1977 NEJM Controlled trial quality: uncertain

12. Treatment of gonorrhea. Penicillin or tetracyclines? (Abstract)

Treatment of gonorrhea. Penicillin or tetracyclines? 4621449 1972 03 23 2016 10 17 0098-7484 219 4 1972 Jan 24 JAMA JAMA Treatment of gonorrhea. Penicillin or tetracyclines? 471-4 Neumann H H HH Baecker J M JM eng Clinical Trial Comparative Study Journal Article Randomized Controlled Trial United States JAMA 7501160 0098-7484 17R794ESYN Penicillin G Procaine 5R5W9ICI6O Demeclocycline F8VB5M810T Tetracycline N12000U13O Doxycycline X20I9EN955 Oxytetracycline AIM IM Administration, Oral Adolescent (...) Adult Demeclocycline therapeutic use Doxycycline therapeutic use Drug Hypersensitivity etiology Gonorrhea drug therapy microbiology Humans Injections, Intramuscular Male Middle Aged Neisseria gonorrhoeae drug effects isolation & purification Oxytetracycline administration & dosage adverse effects therapeutic use Penicillin G Procaine administration & dosage adverse effects therapeutic use Penicillin Resistance Tetracycline administration & dosage adverse effects 1972 1 24 1972 1 24 0 1 1972 1 24 0 0

1972 JAMA Controlled trial quality: uncertain